Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ukai

Showing results (31-40 of 132) with videos related to

Pageof 14
Sort By:
Methods and Findings in Experimental and Clinical Pharmacology|January 27, 1998
Modulatory effects of morphine, U-50488H and 1,3-di-(2-tolyl)guanidine on cocaine-like discriminative stimulus in the rat using two-choice discrete-trial avoidance paradigmM Ukai, E Mori, T Kameyama
Neuropharmacology|October 1, 1988
The opioid antagonist, MR2266, specifically decreases saline intake in the mouseM Ukai, S Nakayama, T Kameyama
Brain Research|June 7, 1988
Apomorphine markedly potentiates naltrexone-induced hypodipsia in the ratM Ukai, S Nakayama, T Kameyama
Journal of Neural Transmission (Vienna, Austria : 1996)|August 31, 2002
Effects of U-50,488H, a kappa-opioid receptor agonist, on the learned helplessness model of depression in miceM Ukai, M Suzuki, T Mamiya
Chemical & Pharmaceutical Bulletin|July 1, 1977
Effects of central muscle relaxants on the morphine-induced Straub tail reactionT Kameyama, T Nabeshima, M Ukai
European Journal of Pharmacology|March 17, 1992
Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in miceT Toyoshi, M Ukai, T Kameyama
Pharmacology, Biochemistry, and Behavior|May 1, 1984
Naloxone reserves the inhibitory effects of dynorphin A on motor activity in the mouseM Ukai, S Yamada, T Kameyama
Nihon Naibunpi Gakkai Zasshi|February 20, 1974
[Proceedings: Effect of glucagon on biosynthesis of cholesterol in the liver]M Ukai, A Tomura, M Ito
Methods and Findings in Experimental and Clinical Pharmacology|November 20, 1998
Ameliorative effects of tachykinins on scopolamine-induced impairment of spontaneous alternation performance in miceT Kameyama, M Ukai, N Shinkai
Brain Research|February 8, 1991
Pentazocine-like discriminative stimulus effects of morphine are blocked by the dopamine D-1 antagonist SCH23390, but not by the dopamine D-2 antagonist sulpirideM Ukai, E Hiraiwa, T Kameyama
Pageof 14

Showing results (31-40 of 132) with videos related to

Sort By:
Pageof 14
Methods and Findings in Experimental and Clinical Pharmacology|January 27, 1998
Modulatory effects of morphine, U-50488H and 1,3-di-(2-tolyl)guanidine on cocaine-like discriminative stimulus in the rat using two-choice discrete-trial avoidance paradigmM Ukai, E Mori, T Kameyama
Neuropharmacology|October 1, 1988
The opioid antagonist, MR2266, specifically decreases saline intake in the mouseM Ukai, S Nakayama, T Kameyama
Brain Research|June 7, 1988
Apomorphine markedly potentiates naltrexone-induced hypodipsia in the ratM Ukai, S Nakayama, T Kameyama
Journal of Neural Transmission (Vienna, Austria : 1996)|August 31, 2002
Effects of U-50,488H, a kappa-opioid receptor agonist, on the learned helplessness model of depression in miceM Ukai, M Suzuki, T Mamiya
Chemical & Pharmaceutical Bulletin|July 1, 1977
Effects of central muscle relaxants on the morphine-induced Straub tail reactionT Kameyama, T Nabeshima, M Ukai
European Journal of Pharmacology|March 17, 1992
Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in miceT Toyoshi, M Ukai, T Kameyama
Pharmacology, Biochemistry, and Behavior|May 1, 1984
Naloxone reserves the inhibitory effects of dynorphin A on motor activity in the mouseM Ukai, S Yamada, T Kameyama
Nihon Naibunpi Gakkai Zasshi|February 20, 1974
[Proceedings: Effect of glucagon on biosynthesis of cholesterol in the liver]M Ukai, A Tomura, M Ito
Methods and Findings in Experimental and Clinical Pharmacology|November 20, 1998
Ameliorative effects of tachykinins on scopolamine-induced impairment of spontaneous alternation performance in miceT Kameyama, M Ukai, N Shinkai
Brain Research|February 8, 1991
Pentazocine-like discriminative stimulus effects of morphine are blocked by the dopamine D-1 antagonist SCH23390, but not by the dopamine D-2 antagonist sulpirideM Ukai, E Hiraiwa, T Kameyama
Pageof 14